NCGFX
Price
$64.53
Change
+$0.69 (+1.08%)
Updated
Jun 6 closing price
Net Assets
514.3M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

NCGFX vs VITSX

Header iconNCGFX vs VITSX Comparison
Open Charts NCGFX vs VITSXBanner chart's image
New Covenant Growth
Price$64.53
Change+$0.69 (+1.08%)
VolumeN/A
Net Assets514.3M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
NCGFX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NCGFX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCGFX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. NCGFX (514M). VITSX pays higher dividends than NCGFX: VITSX (1.29) vs NCGFX (0.62). NCGFX was incepted earlier than VITSX: NCGFX (26 years) vs VITSX (28 years). NCGFX (0.98) is less costly to investors than VITSX (0.03). NCGFX is a more actively managed with annual turnover of: 3.00 vs. VITSX (2.00). NCGFX has a lower initial minimum investment than VITSX: NCGFX (500) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. NCGFX (1.70). VITSX return over 5 years is better than : 80.96 vs. NCGFX (48.48).
NCGFXVITSXNCGFX / VITSX
Total Expense Ratio0.720.032,400%
Annual Report Gross Expense Ratio0.980.033,267%
Fund Existence26 years28 years-
Gain YTD0.5640.83368%
Front LoadN/AN/A-
Min. Initial Investment50050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets514M1.82T0%
Annual Yield % from dividends0.621.2948%
Returns for 1 year1.7010.9715%
Returns for 3 years22.2840.3555%
Returns for 5 years48.4880.9660%
Returns for 10 years79.16180.4944%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.